Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
2.
Radiol Clin North Am ; 51(5): 781-98, 2013 Sep.
Article in English | MEDLINE | ID: mdl-24010906

ABSTRACT

Although positron emission tomography (PET) imaging may not be used in the diagnosis of breast cancer, the use of PET/computed tomography is imperative in all aspects of breast cancer staging, treatment, and follow-up. PET will continue to be relevant in personalized medicine because accurate tumor status will be even more critical during and after the transition from a generic metabolic agent to receptor imaging. Positron emission mammography is an imaging proposition that may have benefits in lower doses, but its use is limited without new radiopharmaceuticals.


Subject(s)
Breast Neoplasms/diagnostic imaging , Multimodal Imaging , Breast Neoplasms/pathology , Female , Fluorodeoxyglucose F18 , Humans , Lymphatic Metastasis , Neoplasm Metastasis/diagnostic imaging , Neoplasm Metastasis/pathology , Neoplasm Staging , Precision Medicine , Prognosis , Radionuclide Imaging , Radiopharmaceuticals , Sensitivity and Specificity
SELECTION OF CITATIONS
SEARCH DETAIL
...